This positive regulatory circuit formed by KCNMB2-AS1 and IGFBP3 significantly induced cervical cancer progression and targeting KCNMB2-AS1 and its related molecules may be a potential detective and therapeutic way for cervical cancer patients [144]. This evidence concerns the gene KCNMB2 and cervical cancer.